AstraZeneca's CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell lymphoma ...

Very often, an ACL tear occurs and there is also a low grade MCL injury. In this situation, the knee is braced to allow the MCL to heal with conservative treatment and then the ACL tear is addressed ...

Houston Texans wide receiver Tank Dell is expected to have surgery on his left knee to begin the process of returning to the ...

David Montgomery missed 3 Detroit Lions games with a torn MCL but is expected to return Saturday vs. Washington Commanders in ...

In this video from , Pamela J. Lund, MD, national director of MSK imaging at SimonMed Imaging, highlights a session on the management of knee disorders in 2025.“We had a great knee session today that ...

Patients who revisit the emergency department shortly after discharge are at high risk for complications and death, exacerbated by COVID-19 screening workload. Detection efforts impact outcomes.

Triptans are highly effective for short-term treatment of acute migraine attacks ... 5 mg orally disintegrating tablets 5 mg/100 mcl nasal spray 2.5 or 5 mg p.o.; can be repeated after 2 h ...

A local physical therapist from HealthQuest provides insight on how athletes, like David Montgomery, recover and rehab ...

The FDA has approved Calquence (acalabrutinib) for use in combination with bendamustine and rituximab to treat adults with previously untreated MCL who are ineligible for transplant.

Montgomery was a full participant in the Detroit Lions' walk-through practice Tuesday after suffering a knee injury in the loss to the Buffalo Bills and missing the last three games of the regular ...